Interested in promotions? | Click here >>
74113
Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit
Primary Antibodies
Antibody Sampler Kit

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit #74113

Reviews ()
Citations (0)
Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 1

Confocal immunofluorescent analysis of mouse subicular cortex from the 5XFAD mouse model of Alzheimer's disease using β-Amyloid (D54D2) XP® Rabbit mAb #8243 (green) and GFAP (GA5) Mouse mAb #3670 (red). Samples were mounted in ProLong® Gold Antifade Reagent with DAPI #8961 (blue).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 2

Confocal immunofluorescent analysis of wild-type (left) and Tg2576 mouse model of Alzheimer's brain (right) using β-Amyloid (1-42 Preferred) (D9A3A) Rabbit mAb (green) and β3-Tubulin (TU-20) Mouse mAb #4466 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 3

Confocal immunofluorescent analysis of hippocampus from wild-type (left) and TG2576 (right) mice using β-Amyloid (1-40 Specific) (D8Q7I) Rabbit mAb (green) and β3-Tubulin (TU-20) Mouse mAb #4466 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 4

Confocal immunofluorescent analysis of brain from the 5XFAD mouse model of Alzheimer's disease using β-Amyloid (1-43 Preferred) (E8C2D) Rabbit mAb (green). After blocking free secondary antibody binding sites with Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, the tissue was then labeled using GFAP (GA5) Mouse mAb (Alexa Fluor® 555 Conjugate) #3656 (red pseudocolor) and β-Amyloid (D54D2) XP® Rabbit mAb (Alexa Fluor® 647 Conjugate) #42284 (yellow pseudocolor). Samples were mounted in ProLong® Gold Antifade Reagent with DAPI #8961 (blue).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 5

Confocal immunofluorescent analysis of wild-type (left) and Tg2576 mouse model of Alzheimer's brain (right) using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb (green) and β3-Tubulin (TU-20) Mouse mAb #4466 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 6

Western blot analysis of normal mouse brain and Tau KO (-/-) mouse brain with Tau (D1M9X) XP® Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). Tau-KO mouse brain tissue was kindly provided by Dr. Dominic Walsh at Brigham and Women's Hospital and Harvard Medical School.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 7

Confocal immunofluorescent analysis of mouse striatum (left), hippocampus (middle), or midbrain (right) using Tau (D1M9X) XP® Rabbit mAb (green) and GFAP (GA5) Mouse mAb #3670 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 8

Confocal immunofluorescent analysis of mouse medulla oblangata using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb (green). Blue = DAPI #4083 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 9

Western blot analysis of normal mouse brain and Tau KO (-/-) mouse brain with Phospho-Tau (Thr205) (E7D3E) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). Tau-KO mouse brain tissue was kindly provided by Dr. Dominic Walsh at Brigham and Women's Hospital and Harvard Medical School.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 10

Confocal immunofluorescent analysis of Tg2576 mouse brain, untreated (left) or Lambda Protein Phosphatase-treated (right), using Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) (red) and GFAP (GA5) Mouse mAb #3670 (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 11

Western blot analysis of normal mouse brain and Tau KO (-/-) mouse brain with Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). Tau-KO mouse brain tissue was kindly provided by Dr. Dominic Walsh at Brigham and Women's Hospital and Harvard Medical School.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 12

Immunohistochemical analysis of paraffin-embedded human Alzheimer's brain using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 13

Western blot analysis of normal mouse brain and Tau KO (-/-) mouse brain with Phospho-Tau (Thr181) (D9F4G) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). Tau-KO mouse brain tissue was kindly provided by Dr. Dominic Walsh at Brigham and Women's Hospital and Harvard Medical School.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 14

Confocal immunofluorescent analysis of mouse brainstem using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb #12885 (green) and S6 Ribosomal Protein (54D2) Mouse mAb #2317 (red). Antibody was pre-incubated with non-phospho-Tau (Thr181) peptide (left), a phospho-Tau (Thr181) peptide (middle), or without peptide (right) to confirm phospho-specificity. Samples were mounted in ProLong® Gold Antifade Reagent with DAPI #8961 (blue).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 15

After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO® is added and emits light during enzyme catalyzed decomposition.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 16

Western blot analysis of human Aβ-42, Aβ-40, Aβ-39, Aβ-38, and Aβ-37 peptides (5 ng) using β-Amyloid (D54D2) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 17

Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, and Aβ-42 peptides (2.5 ng) using β-Amyloid (1-42 Preferred) (D9A3A) Rabbit mAb (upper) and β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 18

Western blot analysis of brain extracts from 13-month old wild-type and TG2576 mice using β-Amyloid (1-40 Specific) (D8Q7I) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 19

Western blot analysis with the indicated amounts of human β-amyloid (1-43) protein using β-Amyloid (1-43 Preferred) (E8C2D) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 20

Immunohistochemical analysis of paraffin-embedded human Alzheimer's brain using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 21

Western blot analysis of extracts from various cell lines and tissues using Tau (D1M9X) XP® Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 22

Confocal immunofluorescent analysis of T-47D (positive, left) or MDA-MB-231 (negative, right) cells using Tau (D1M9X) XP® Rabbit mAb (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 23

Confocal immunofluorescent analysis of dentate gyrus in wild-type mouse brain using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb (green). Antibody was pre-incubated with a non-phospho-Tau peptide (left), a phospho-Tau (Thr205) peptide (center), or without peptide (right) to confirm phospho-specificity. Samples were mounted in ProLong® Gold Antifade Reagent with DAPI #8961 (blue).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 24

Western blot analysis of extracts from mouse brain, untreated (-) or phosphatase-treated (+), and rat brain using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb (upper) and Tau (D1M9X) Rabbit mAb #46687 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 25

Confocal immunofluorescent analysis of mouse primary neurons using Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) (green). Blue pseudocolor = Hoescht 33342 #4082 (fluorescent DNA dye).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 26

Western blot analysis of extracts from human cortex (lane 1), neonatal mouse brain, untreated (lane 2) or phosphatase-treated (lane 3), and fetal rat brain (lane 4), using Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) (upper), Tau (Tau46) Mouse mAb #4019 (middle) and β-Actin (D6A8) Rabbit mAb #8457 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 27

Western blot analysis of extracts from mouse and rat brain using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb. The phospho-specificity of Phospho-Tau (Thr181) (D9F4G) Rabbit mAb was verified by peptide blocking using a phosphopeptide or non-phosphopeptide targeting residue Thr181.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 28

Western blot analysis of the indicated amounts of human Aβ-42 (left) and Aβ-40 (right) peptides using β-Amyloid (D54D2) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 29

Western blot analysis of brain extracts from 13-month old wild-type and Tg2576 mouse model of Alzheimer's brain using β-Amyloid (1-42 Preferred) (D9A3A) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 30

Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42 and Aβ-43 peptides (10 ng) using β-Amyloid (1-40 Specific) (D8Q7I) Rabbit mAb (upper) and β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 31

Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42 and Aβ-43 peptides (10 ng) using β-Amyloid (1-43 Preferred) (E8C2D) Rabbit mAb. Note the slight cross-reactivity with Aβ-42.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 32

Immunohistochemical analysis of paraffin-embedded Tg2576 mouse model of Alzheimer's brain using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 33

Immunohistochemical analysis of paraffin-embedded human Alzheimer's brain using Tau (D1M9X) XP® Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 34

Immunohistochemical analysis of paraffin-embedded human Alzheimer's disease brain using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb in the presence of non-phospho-Tau (Thr205) peptide (left) or phospho-Tau (Thr205) peptide (right).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 35

Western blot analysis of extracts from MEF cells (lane 1) and mouse brain (lane 2) using Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) (upper), Tau (Tau46) Mouse mAb #4019 (middle) and β-Actin (D6A8) Rabbit mAb #8457 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 36

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 37

Western blot analysis of human Aβ-42 peptide (1 ng) and human cerebrospinal fluid (CSF) of an AD patient using β-Amyloid (D54D2) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 38

β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb specificity is demonstrated using peptide dot blot. β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb binds to pre-coated β-amyloid (pE3) peptide but not to β-amyloid (E3) peptide or scrambled β-amyloid (pE3) peptide.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 39

Immunohistochemical analysis of paraffin-embedded human normal appendix using Tau (D1M9X) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 40

Immunohistochemical analysis of paraffin-embedded mouse brain using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 41

Immunohistochemical analysis of paraffin-embedded mouse brain using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 42

Western blot analysis of the indicated amounts of human Aβ (pE3-42) and Aβ (1-42) peptides using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb (upper) and β-Amyloid (1-42 Specific) (D3E10) Rabbit mAb #12843 (lower).

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 43

Immunohistochemical analysis of paraffin-embedded T-47D cell pellet (left, positive) or MDA-MB-231 cell pellet (right, negative) using Tau (D1M9X) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 44

Immunohistochemical analysis of paraffin-embedded mouse small intestine using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 45

Immunohistochemical analysis of paraffin-embedded mouse colon, control (left) or λ phosphatase-treated (right), using Phospho-Tau (Thr181) (D9F4G) Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 46

Immunohistochemical analysis of paraffin-embedded mouse lung using Tau (D1M9X) XP® Rabbit mAb.

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit: Image 47

Immunoprecipitation of Phospho-Tau (Thr205) from mouse brain lysates. Lane 1 mouse brain lysate immunoprecipitation, lane 2 is Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, lanes 3, 4, and 5 represent three dilutions of the immunoprecipitation of mouse brain lysates at 1:50, 1:100, 1:200 respectively, and lane 6 is mouse brain lysate. Western blot analysis was performed using Phospho-Tau (Thr205) (E7D3E) Rabbit mAb.

To Purchase # 74113T
Product # Size Price
74113T
1 Kit  (9 x 20 µl) $ 609

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
β-Amyloid (D54D2) XP® Rabbit mAb 8243 20 µl
  • WB
  • IP
  • IF
H 5 Rabbit IgG
β-Amyloid (1-42 Preferred) (D9A3A) Rabbit mAb 14974 20 µl
  • WB
  • IF
H 4 Rabbit IgG
β-Amyloid (1-40 Specific) (D8Q7I) Rabbit mAb 12990 20 µl
  • WB
  • IF
H 4 Rabbit IgG
β-Amyloid (1-43 Preferred) (E8C2D) Rabbit mAb 32098 20 µl
  • WB
  • IF
H 6 Rabbit IgG
β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb 14975 20 µl
  • WB
  • IHC
  • IF
H 4 Rabbit IgG
Tau (D1M9X) XP® Rabbit mAb 46687 20 µl
  • WB
  • IHC
  • IF
H M R 50 to 80 Rabbit IgG
Phospho-Tau (Thr205) (E7D3E) Rabbit mAb 49561 20 µl
  • WB
  • IP
  • IHC
  • IF
H M R 50-80 Rabbit IgG
Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) 20194 20 µl
  • WB
  • IP
  • IF
H M R 50-80 Rabbit IgG
Phospho-Tau (Thr181) (D9F4G) Rabbit mAb 12885 20 µl
  • WB
  • IP
  • IHC
  • IF
H M R 50-80 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
  • WB
Goat 

Product Description

The Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit provides an economical means of detecting the activation of Tau and APP family members using phospho-specific, and control antibodies for both proteins. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.

Specificity / Sensitivity

Pathological Hallmarks of Alzheimer's Disease Antibody Sampler Kit includes Tau (D1M9X) XP® Rabbit mAb that recognizes total tau, and antibodies that recognize various phosphorylated tau epitopes found in Alzheimer's disease, including Phospho-Tau (Thr205) (E7D3E), Phospho-Tau (Ser404) (D2Z4G) (IF preferred), and Phospho-Tau (Thr181) (D9F4G). Additionally, this kit includes antibodies that detect various β-Amyloid peptides of the APP human protein, including β-Amyloid (D54D2) XP® Rabbit mAb, which also detects transgenically expressed human APP in mouse. β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb recognizes recombinant pE3 peptides but does not cross-react with the non-E3 peptides. β-Amyloid (1-40 Specific) (D8Q7I) Rabbit mAb does not cross-react with other β-amyloid peptides. β-Amyloid (1-43 Preferred) (E8C2D) Rabbit mAb and β-Amyloid (1-42 preferred) (D9A3A) Rabbit mAb both detect transgenically expressed human APP in mouse models.

Source / Purification

Tau antibodies include peptides corresponding to residues surrounding Asp430, phosphorylated at Thr205, Ser400/Thr403/Ser404, and Thr181 of human tau. Monoclonal antibodies are produced by immunizing rabbits with synthetic Aβ peptides corresponding to residues near the carboxy terminus of human β-amyloid (1-42), (1-40), (1-43), (pE3) peptide, and several peptides of Aβ, such as Aβ-37, Aβ-38, Aβ-39, Aβ-40, and Aβ-42.

Background

Tau is a heterogeneous microtubule-associated protein that promotes and stabilizes microtubule assembly, especially in axons. Six isoforms with different amino-terminal inserts and different numbers of tandem repeats near the carboxy terminus have been identified, and tau is hyperphosphorylated at approximately 25 sites by ERK, GSK-3, and CDK5 (1,2). Phosphorylation decreases the ability of tau to bind to microtubules. Neurofibrillary tangles are a major hallmark of Alzheimer's disease; these tangles are bundles of paired helical filaments composed of hyperphosphorylated tau. In particular, phosphorylation at Ser396 by GSK-3 or CDK5 destabilizes microtubules. Furthermore, research studies have shown that inclusions of tau are found in a number of other neurodegenerative diseases, collectively known as tauopathies (1,3). The cerebrospinal fluid concentration of tau phosphorylated at Thr181 has been proposed to be a biomarker for the study of neurodegenerative disorders (4).

Amyloid β (Aβ) precursor protein (APP) is a 100-140 kDa transmembrane glycoprotein that exists as several isoforms (4). The amino acid sequence of APP contains the amyloid domain, which can be released by a two-step proteolytic cleavage (4). The extracellular deposition and accumulation of the released Aβ fragments form the main components of amyloid plaques in Alzheimer's disease (4). APP can be phosphorylated at several sites, which may affect the proteolytic processing and secretion of this protein (5-8). Aβ-43 has been suggested as a biomarker in early onset of Alzheimer's disease, where patients have lower levels of Aβ-43 in cerebrospinal fluid (8-10). Several studies have shown that Aβ toxicity of Aβ-43 is as high as Aβ-42 or Aβ-40 in different models of Alzheimer's disease, including mouse models and human disease (10).

  1. Johnson, G.V. and Stoothoff, W.H. (2004) J Cell Sci 117, 5721-9.
  2. Hanger, D.P. et al. (1998) J Neurochem 71, 2465-76.
  3. Bramblett, G.T. et al. (1993) Neuron 10, 1089-99.
  4. Mitchell, A.J. (2009) J Neurol Neurosurg Psychiatry 80, 966-75.
  5. Selkoe, D.J. (1996) J Biol Chem 271, 18295-8.
  6. Caporaso, G.L. et al. (1992) Proc Natl Acad Sci USA 89, 3055-9.
  7. Hung, A.Y. and Selkoe, D.J. (1994) EMBO J 13, 534-42.
  8. Suzuki, T. et al. (1994) EMBO J 13, 1114-22.
  9. Ando, K. et al. (1999) J Neurosci 19, 4421-7.
  10. Iijima, K. et al. (2000) J Neurochem 75, 1085-91.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.